EP Patent

EP1924292A2 — Compositions and methods for the intraocular transport of therapeutic agents

Assigned to Allergan Inc · Expires 2008-05-28 · 18y expired

What this patent protects

Membrane transporter-targeted therapeutic agents and methods of making and using the same.

USPTO Abstract

Membrane transporter-targeted therapeutic agents and methods of making and using the same.

Drugs covered by this patent

Patent Metadata

Patent number
EP1924292A2
Jurisdiction
EP
Classification
—
Expires
2008-05-28
Drug substance claim
No
Drug product claim
No
Assignee
Allergan Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.